Cannabis Bioscience International Holdings, Inc.
CBIH
$0.0008
$0.000114.29%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 74.20K | 178.90K | 75.90K | 36.40K | 63.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.20K | 178.90K | 75.90K | 36.40K | 63.70K |
| Cost of Revenue | 7.80K | 8.40K | 9.90K | 11.80K | 15.10K |
| Gross Profit | 66.40K | 170.50K | 66.00K | 24.60K | 48.70K |
| SG&A Expenses | 126.10K | 268.10K | 95.60K | 184.60K | 143.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 133.90K | 276.50K | 105.50K | 196.40K | 158.30K |
| Operating Income | -59.60K | -97.60K | -29.60K | -160.00K | -94.50K |
| Income Before Tax | -79.50K | -76.30K | -135.90K | -209.20K | -124.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -79.50K | -76.30K | -135.90K | -209.20K | -124.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -79.50K | -76.30K | -135.90K | -209.20K | -124.40K |
| EBIT | -59.60K | -97.60K | -29.60K | -160.00K | -94.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 10.50B | 10.46B | 10.32B | 10.37B | 10.33B |
| Average Diluted Shares Outstanding | 10.50B | 10.46B | 10.32B | 10.37B | 10.33B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
